ProPhase Labs, Inc.
Market Cap
$663.18K
P/E Ratio
-0.01
EPS
$-19.80
Dividend Yield
0.00%
52-Week Range
$0.07 — $6.70
Volume
44.44K
Avg Volume
197.82K
Beta
-0.32
Get alerted when PRPH hits your target price.
Free — enter your email to get started
P/E (TTM)
-0.01
Forward P/E
0.01
PEG Ratio
-0.00
P/S (TTM)
0.48
P/B (TTM)
0.07
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-4.04%
ROA (TTM)
-0.63%
ROIC
—
Gross Margin
1.91%
Operating Margin
-24.97%
Net Margin
—
Debt/Equity
1.12
Current Ratio
0.14
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.55%
EPS Growth (5Y)
+0.33%
Sales Growth (3Y)
-0.31%
Sales Growth (5Y)
+0.80%
EPS Est (This Year)
$10.40
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.10
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
4.74M
Float
4.32M
Free Float %
91.20%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
Exchange
NASDAQ
IPO Date
1994-04-04
Employees
96
CEO
Ted William Karkus
Index Membership
—
Website
https://www.prophaselabs.com
ProPhase Labs, Inc. (PRPH) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $663.18K, a P/E ratio of -0.01, PRPH is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare PRPH against other stocks using dozens of fundamental and technical filters.
SXTC
China SXT Pharmaceuticals, Inc.
$2.07
+0.49%
$1.60M
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$0.69
-32.84%
$740.65K
CHLL.L
Chill Brands Group PLC
$0.40
+0.00%
$2.09M
APUS
Apimeds Pharmaceuticals US, Inc
$1.88
+0.00%
$2.36M
CANB.V
CanadaBis Capital Inc.
$0.01
+0.00%
$2.07M
SNOA
Sonoma Pharmaceuticals, Inc.
$1.20
+9.09%
$2.09M
ProPhase Labs, Inc. (PRPH) has a trailing twelve-month (TTM) P/E ratio of -0.01. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, ProPhase Labs, Inc. (PRPH) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
ProPhase Labs, Inc. (PRPH) has a market capitalization of $663,181, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.